RVNC

Revance Therapeutics, Inc.

Delisted

RVNC was delisted on the 5th of February, 2025.

199 hedge funds and large institutions have $429M invested in Revance Therapeutics, Inc. in 2024 Q3 according to their latest regulatory filings, with 71 funds opening new positions, 40 increasing their positions, 54 reducing their positions, and 44 closing their positions.

Holders
199
Holders Change
+27
Holders Change %
+15.7%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
71
Increased
40
Reduced
54
Closed
44
Calls
$4.42M
Puts
$5.33M
Net Calls
-$909K
Net Calls Change
-$1.71M
Name Market Value Shares Shares
Change
Shares
Change %
BHMP
251
Bardin Hill Management Partners
New York